GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Effective Interest Rate on Debt %

Universal Ibogaine (TSXV:IBO) Effective Interest Rate on Debt % : 5.84% (As of Jan. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Effective Interest Rate on Debt %?

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Universal Ibogaine's annualized positive value of Interest Expense for the quarter that ended in Jan. 2024 was C$0.16 Mil. Universal Ibogaine's average total debt for the quarter that ended in Jan. 2024 was C$2.81 Mil. Therefore, Universal Ibogaine's annualized Effective Interest Rate on Debt % for the quarter that ended in Jan. 2024 was 5.84%.


Universal Ibogaine Effective Interest Rate on Debt % Historical Data

The historical data trend for Universal Ibogaine's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Effective Interest Rate on Debt % Chart

Universal Ibogaine Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Jul22 Jul23
Effective Interest Rate on Debt %
Get a 7-Day Free Trial - - - 7.56 6.78

Universal Ibogaine Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.29 8.92 2.21 6.29 5.84

Competitive Comparison of Universal Ibogaine's Effective Interest Rate on Debt %

For the Biotechnology subindustry, Universal Ibogaine's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Universal Ibogaine's Effective Interest Rate on Debt % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Effective Interest Rate on Debt % falls into.



Universal Ibogaine Effective Interest Rate on Debt % Calculation

Universal Ibogaine's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Jul. 2023 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Jul. 2022 )+Total Debt  (A: Jul. 2023 ))/ count )
=-1  *  -0.153/( (1.738+2.777)/ 2 )
=-1  *  -0.153/2.2575
=6.78 %

where

Total Debt  (A: Jul. 2022 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.18 + 1.558
=1.738

Total Debt  (A: Jul. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.962 + 1.815
=2.777

Universal Ibogaine's annualized Effective Interest Rate on Debt % for the quarter that ended in Jan. 2024 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Oct. 2023 )+Total Debt  (Q: Jan. 2024 ))/ count )
=-1  *  -0.164/( (2.823+2.797)/ 2 )
=-1  *  -0.164/2.81
=5.84 %

where

Total Debt  (Q: Oct. 2023 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=1.026 + 1.797
=2.823

Total Debt  (Q: Jan. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=2.666 + 0.131
=2.797

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Jan. 2024) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.


Universal Ibogaine  (TSXV:IBO) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Universal Ibogaine Effective Interest Rate on Debt % Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Effective Interest Rate on Debt % provided by GuruFocus.com. Please click on the following links to see related term pages.


Universal Ibogaine (TSXV:IBO) Business Description

Industry
Traded in Other Exchanges
Address
400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2
Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.
Executives
Ian Rabb Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines